Member Exclusive

Pfizer and Concerto HealthAI partner to develop cancer therapies

Concerto HealthAI (MA, USA) has entered into collaboration with Pfizer (NY, USA), to make use of real-world data and provide actionable patient insights for Pfizer’s investigational therapies and commercialized therapeutics used to treat solid tumors and hematologic malignancies.

Go to the profile of Zoe Campbell
May 02, 2019
0
0

Please sign in or register for FREE

No comments yet.